Salubris Biotherapeutics
Developing innovative and transformative therapeutic molecules to provide clinically meaningful improvements in disease burden and quality of life to patients with significant medical needs. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$140—210m (Dealroom.co estimates Apr 2024.)
Gaithersburg Maryland (HQ)
Authorizing premium user...